Position in ABBV
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$30,795,954
+$4,780,888 QoQ
Shares Held
122,381
+2.3% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.69%
of 13F equity value
Holder Rank
#478
of 4,153 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 13%
Shared 0%
None 87%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Apollon Wealth Management, LLC holds $214,410,726 across 14 Drug Manufacturers - General names. ABBV ranks #3 (14.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
67,842 | $81,371,736 | |
| 2 | JNJ |
Johnson & Johnson
|
161,278 | $40,959,773 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
122,381 | $30,795,954 | |
| 4 | AZN |
Astrazeneca PLC
|
97,297 | $18,449,457 | |
| 5 | MRK |
Merck & Co., Inc.
|
96,041 | $12,341,268 | |
| 6 | AMGN |
Amgen Inc
|
23,363 | $8,460,209 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
104,485 | $6,020,425 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
38,585 | $4,874,828 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $30,795,954 | 122,381 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $26,015,066 | 119,615 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $25,585,624 | 111,977 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $18,996,699 | 82,045 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $14,945,565 | 80,517 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $16,763,485 | 80,009 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $14,079,171 | 79,230 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $14,025,227 | 71,021 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $11,737,285 | 68,431 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $12,250,777 | 67,275 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $10,356,800 | 66,831 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $7,144,296 | 47,929 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $6,499,105 | 48,238 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $8,133,607 | 51,036 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $7,611,992 | 47,101 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $5,572,264 | 41,519 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $6,103,272 | 39,849 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $6,486,993 | 40,016 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $5,718,619 | 42,235 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,650,042 | 24,567 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,627,535 | 14,449 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $1,587,587 | 14,670 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $268,196 | 2,503 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $367,965 | 4,201 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $213,345 | 2,173 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||